Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Medical Oncology Physician in Galveston, TX
NPI: 1336155662Primary Practice Location
UNIVERSITY OF TEXAS MEDICAL BRANCH GALVESTON
301 8th St, Galveston, TX
Primary Employer
Utmb Faculty Group Practice
utmb.edu
HQ Phone
Get M.D. Avi's Phone Numberphone_androidMobile
Get M.D. Avi's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
CA State Medical License
1982
FL State Medical License
2021
TX State Medical License
1988 - 2027
American Board of Internal Medicine
Internal Medicine
National Board of Physicians and Surgeons
Internal Medicine
National Board of Physicians and Surgeons
Medical Oncology
UCSF School of Medicine
medschool.ucsf.edu
Medical School
Until 1981
University of California (San Diego) Medical Center
Residency • Internal Medicine
1981 - 1984
Rutgers College
Biochemistry
1974 - 1977
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 46 | 78 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 32 | 67 |
| 3 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 20 | 21 |
A Case of Philadelphia Chromosome Positive Myeloproliferative Neoplasm in a Pregnant Woman with Unusual Primary Myelofibrosis Features
Authors: Jack Alperin, Bagi Jana
Publication Date: 2013-05
Authors: Vassilopoulou-Sellin, R, Thielvoldt, D, Markowitz, A B
Journal: Blood
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Fulvestrant, DRUG: Copanlisib
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, RADIATION: Radiation Therapy, DRUG: Berzosertib
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: United States Department of Defense, National Cancer Institute (NCI), Bayer, Canadian Cancer Trials Group
Intervention / Treatment: OTHER: Placebo, DRUG: Aspirin
